Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Sire Bioscience Inc. C.SIRE

SIRE BIOSCIENCE is a Life Science company and a Health Canada License holder under the Cannabis Act and the Industrial Hemp Regulations. SIRE owns 50 Acres of prime agricultural land in Leamington, ON, consisting of 137,000 sq ft greenhouse.

CSE:SIRE - Post Discussion

Sire Bioscience Inc. > FUEL You must all place your sell orders at 0.18¢
View:
Post by Traderstock101 on Mar 01, 2024 10:32am

FUEL You must all place your sell orders at 0.18¢

Because a very rapid rise is being prepared on the next very important news to come
Comment by Ventrue on Mar 01, 2024 12:04pm
Years ago there was a very successful analyst who championed a system he called bottom-fishing, which was a contrarian way to invest in high risk spec stocks that seemingly had various pieces of their puzzle slowly coming into place.  This feels like one of those situations
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities